Yoshio Kurihara

Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)

Hiroki Yokoyama, Mariko Oishi, Hiroshi Takamura et al. · BMJ Open Diabetes Research & Care · 2016 · 84 citations · Full text

Medicine, Internal Medicine, Diabetology +16

A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1)

Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto et al. · PLoS ONE · 2016 · 57 citations · Full text

Medicine, Endocrinology, Pharmacology +12

Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone

Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori et al. · Journal of Diabetes Investigation · 2020 · 55 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2)

Hiroshi Nomoto, Hideaki Miyoshi, Tomoo Furumoto et al. · PLoS ONE · 2015 · 53 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial

Takahiro Takase, Akinobu Nakamura, Hiroshi Nomoto et al. · Journal of Diabetes Investigation · 2018 · 47 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17